• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine.对土拉弗朗西斯菌 O-多糖的遗传修饰导致一种无毒的活减毒疫苗。
J Infect Dis. 2012 Apr 1;205(7):1056-65. doi: 10.1093/infdis/jir620. Epub 2011 Oct 3.
2
A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity.土拉弗朗西斯菌活疫苗株的一种确定的O抗原多糖突变体毒性减弱,同时保留了其保护能力。
Infect Immun. 2007 May;75(5):2591-602. doi: 10.1128/IAI.01789-06. Epub 2007 Feb 12.
3
A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.一株编码一种假定荚膜生物合成蛋白的 capB 缺失的活疫苗弗朗西斯氏菌(LVS)突变体比 LVS 显著减毒,但能诱导小鼠对弗朗西斯氏菌挑战产生强烈的保护性免疫。
Infect Immun. 2010 Oct;78(10):4341-55. doi: 10.1128/IAI.00192-10. Epub 2010 Jul 19.
4
Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent subsp. .减毒活土拉弗朗西丝菌疫苗对呼吸道感染强毒. 亚种的保护作用。
Front Cell Infect Microbiol. 2018 May 15;8:154. doi: 10.3389/fcimb.2018.00154. eCollection 2018.
5
Attenuation and protective efficacy of an O-antigen-deficient mutant of Francisella tularensis LVS.土拉热弗朗西斯菌LVS O抗原缺陷突变株的减毒作用及保护效力
Microbiology (Reading). 2007 Sep;153(Pt 9):3141-3153. doi: 10.1099/mic.0.2007/006460-0.
6
Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.细胞免疫和体液免疫在抵御A型和B型土拉弗朗西斯菌方面具有协同作用。
Vaccine. 2009 Jan 22;27(4):597-605. doi: 10.1016/j.vaccine.2008.10.079. Epub 2008 Nov 18.
7
Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.新型减毒靶向缺失突变株弗朗西斯氏菌亚种土拉弗朗西斯菌 SCHU S4 对小鼠气溶胶攻毒的保护作用不同:宿主背景和免疫途径的影响。
Vaccine. 2010 Feb 17;28(7):1824-31. doi: 10.1016/j.vaccine.2009.12.001. Epub 2009 Dec 16.
8
Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.用土拉弗朗西斯菌活疫苗株(LVS)对小鼠进行口服免疫,可保护小鼠免受强毒A型土拉弗朗西斯菌的呼吸道攻击。
Vaccine. 2007 May 10;25(19):3781-91. doi: 10.1016/j.vaccine.2007.02.014. Epub 2007 Feb 26.
9
Further Characterization of the Capsule-Like Complex (CLC) Produced by Subspecies : Protective Efficacy and Similarity to Outer Membrane Vesicles.进一步描述由亚种产生的胶囊样复合物(CLC):保护效力和与外膜囊泡的相似性。
Front Cell Infect Microbiol. 2018 Jun 15;8:182. doi: 10.3389/fcimb.2018.00182. eCollection 2018.
10
An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.一种用于预防由土拉热弗朗西斯菌SchuS4菌株引起的呼吸道兔热病的改良疫苗。
Vaccine. 2008 Sep 26;26(41):5276-88. doi: 10.1016/j.vaccine.2008.07.051. Epub 2008 Aug 8.

引用本文的文献

1
Recent insights into Wzy polymerases and lipopolysaccharide O-antigen biosynthesis.关于Wzy聚合酶与脂多糖O抗原生物合成的最新见解。
J Bacteriol. 2025 Apr 17;207(4):e0041724. doi: 10.1128/jb.00417-24. Epub 2025 Mar 11.
2
TolC facilitates the intracellular survival and immunomodulation of Typhi in human host cells.TolC 有助于伤寒沙门氏菌在人体宿主细胞内的存活和免疫调节。
Virulence. 2024 Dec;15(1):2395831. doi: 10.1080/21505594.2024.2395831. Epub 2024 Sep 9.
3
Development, Strategies, and Challenges for Tularemia Vaccine.土拉菌病疫苗的研发、策略及挑战。
Curr Microbiol. 2024 Apr 2;81(5):126. doi: 10.1007/s00284-024-03658-0.
4
Why vary what's working? Phase variation and biofilm formation in .为何要改变有效的方法?……中的相变和生物膜形成
Front Microbiol. 2022 Dec 6;13:1076694. doi: 10.3389/fmicb.2022.1076694. eCollection 2022.
5
A Historical Review of Military Medical Strategies for Fighting Infectious Diseases: From Battlefields to Global Health.抗击传染病的军事医学策略历史回顾:从战场到全球健康
Biomedicines. 2022 Aug 22;10(8):2050. doi: 10.3390/biomedicines10082050.
6
Phase Variation of LPS and Capsule Is Responsible for Stochastic Biofilm Formation in .脂多糖和荚膜的相变异导致 生物膜形成的随机性。
Front Cell Infect Microbiol. 2022 Jan 14;11:808550. doi: 10.3389/fcimb.2021.808550. eCollection 2021.
7
Development, Phenotypic Characterization and Genomic Analysis of a Panel for Tularemia Vaccine Testing.兔热病疫苗测试组的开发、表型特征分析及基因组分析
Front Microbiol. 2021 Aug 11;12:725776. doi: 10.3389/fmicb.2021.725776. eCollection 2021.
8
Deletion Mutants of Phagosomal Transporters FptA and FptF Are Highly Attenuated for Virulence and Are Protective Against Lethal Intranasal LVS Challenge in a Murine Model of Respiratory Tularemia.吞噬体转运蛋白FptA和FptF的缺失突变体在毒力上高度减弱,并在呼吸道土拉菌病小鼠模型中对致死性鼻内LVS攻击具有保护作用。
Pathogens. 2021 Jun 24;10(7):799. doi: 10.3390/pathogens10070799.
9
Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to .用基因修饰 O 抗原的糖缀合物疫苗诱导针对 的保护性抗体。
Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):7062-7070. doi: 10.1073/pnas.1900144116. Epub 2019 Mar 14.
10
Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent subsp. .减毒活土拉弗朗西丝菌疫苗对呼吸道感染强毒. 亚种的保护作用。
Front Cell Infect Microbiol. 2018 May 15;8:154. doi: 10.3389/fcimb.2018.00154. eCollection 2018.

本文引用的文献

1
Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis.鉴定、表征及弗氏志贺菌 O 抗原荚膜多糖的免疫原性。
PLoS One. 2010 Jul 6;5(7):e11060. doi: 10.1371/journal.pone.0011060.
2
Characterization of the O-antigen polymerase (Wzy) of Francisella tularensis.鉴定土拉弗朗西斯菌 O-抗原聚合酶(Wzy)。
J Biol Chem. 2010 Sep 3;285(36):27839-49. doi: 10.1074/jbc.M110.143859. Epub 2010 Jul 6.
3
Vaccination with a defined Francisella tularensis subsp. novicida pathogenicity island mutant (DeltaiglB) induces protective immunity against homotypic and heterotypic challenge.用特定的土拉弗朗西斯菌新凶手亚种致病岛突变体(ΔiglB)进行疫苗接种可诱导针对同型和异型攻击的保护性免疫。
Vaccine. 2009 Sep 18;27(41):5554-61. doi: 10.1016/j.vaccine.2009.07.034. Epub 2009 Aug 3.
4
Identification of migR, a regulatory element of the Francisella tularensis live vaccine strain iglABCD virulence operon required for normal replication and trafficking in macrophages.鉴定migR,它是土拉弗朗西斯菌活疫苗株iglABCD毒力操纵子的一个调控元件,该元件是巨噬细胞中正常复制和转运所必需的。
Infect Immun. 2009 Jun;77(6):2517-29. doi: 10.1128/IAI.00229-09. Epub 2009 Apr 6.
5
Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge.土拉弗朗西斯菌脂多糖诱导产生的抗原特异性B-1a抗体可提供针对土拉弗朗西斯菌LVS攻击的长期保护。
Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4343-8. doi: 10.1073/pnas.0813411106. Epub 2009 Feb 26.
6
Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis.细胞免疫和体液免疫在抵御A型和B型土拉弗朗西斯菌方面具有协同作用。
Vaccine. 2009 Jan 22;27(4):597-605. doi: 10.1016/j.vaccine.2008.10.079. Epub 2008 Nov 18.
7
Identification of an essential Francisella tularensis subsp. tularensis virulence factor.鉴定土拉弗朗西斯菌兔热病亚种的一种必需毒力因子。
Infect Immun. 2009 Jan;77(1):152-61. doi: 10.1128/IAI.01113-08. Epub 2008 Nov 3.
8
Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis.针对细胞内病原体土拉弗朗西斯菌的体液免疫和细胞介导免疫。
Immunol Rev. 2008 Oct;225:244-55. doi: 10.1111/j.1600-065X.2008.00689.x.
9
An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.一种用于预防由土拉热弗朗西斯菌SchuS4菌株引起的呼吸道兔热病的改良疫苗。
Vaccine. 2008 Sep 26;26(41):5276-88. doi: 10.1016/j.vaccine.2008.07.051. Epub 2008 Aug 8.
10
A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge.一株土拉弗朗西斯菌舒氏亚种S4嘌呤营养缺陷型菌株在小鼠中高度减毒,但对同源鼻内攻击的保护作用有限。
PLoS One. 2008 Jun 25;3(6):e2487. doi: 10.1371/journal.pone.0002487.

对土拉弗朗西斯菌 O-多糖的遗传修饰导致一种无毒的活减毒疫苗。

Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine.

机构信息

Department of Microbiology and Molecular Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02215, USA.

出版信息

J Infect Dis. 2012 Apr 1;205(7):1056-65. doi: 10.1093/infdis/jir620. Epub 2011 Oct 3.

DOI:10.1093/infdis/jir620
PMID:21969334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3295600/
Abstract

BACKGROUND

Francisella tularensis, the causative agent of tularemia, is a highly virulent microbe. One significant virulence factor of F. tularensis is the O-polysaccharide (O-PS) portion of the organism's lipopolysaccharide.

METHODS

A wzy (O-antigen polymerase) deletion mutant of Ft. live attenuated vaccine strain (Ft.LVS), designated Ft.LVS::Δwzy, was created and evaluated as a live attenuated vaccine. Specifically, the mutant's virulence potential and its protective efficacy against type A and type B strains were investigated by challenge of immunized mice.

RESULTS

F. tularensis LVS::Δwzy expressed only 1 repeating unit of O-PS and yet, upon immunization, induced O-PS-specific antibodies. Compared with Ft.LVS, the mutant was highly sensitive to complement-mediated lysis, significantly attenuated in virulence, and was recovered in much lower numbers from the organs of infected mice. Intranasal immunization with Ft.LVS::Δwzy provided protection against subsequent intranasal infection with the highly virulent type A strain SchuS4 and with Ft.LVS. Immunization with Ft.LVS::Δwzy elicited both humoral and cell-mediated immunity.

CONCLUSIONS

Ft.LVS::Δwzy was avirulent in mice and, despite expressing only 1 repeating unit of the O-PS, induced antibodies to the full-length O-PS. Vaccination with Ft.LVS::Δwzy protected mice against intranasal challenge with both type A and type B strains of F. tularensis and induced functional immunity through both humoral and cellular mechanisms.

摘要

背景

土拉弗朗西斯菌是土拉菌病的病原体,是一种高度致病的微生物。土拉弗朗西斯菌的一个重要毒力因子是其脂多糖的 O-多糖(O-PS)部分。

方法

创建并评估了弗氏柠檬酸杆菌活减毒疫苗株(Ft.LVS)的 wzy(O-抗原聚合酶)缺失突变体(Ft.LVS::Δwzy)作为活减毒疫苗。具体而言,通过免疫小鼠的挑战来研究突变体的毒力潜力及其对 A 型和 B 型菌株的保护效力。

结果

弗氏柠檬酸杆菌 LVS::Δwzy 仅表达 1 个 O-PS 重复单元,但在免疫后诱导了 O-PS 特异性抗体。与 Ft.LVS 相比,该突变体对补体介导的裂解高度敏感,毒力显著减弱,并且从感染小鼠的器官中回收的数量明显减少。鼻内免疫 Ft.LVS::Δwzy 可提供针对随后鼻内感染高致病性 A 型菌株 SchuS4 和 Ft.LVS 的保护。Ft.LVS::Δwzy 免疫引发体液和细胞介导的免疫。

结论

Ft.LVS::Δwzy 在小鼠中无致病性,尽管仅表达 1 个 O-PS 重复单元,但诱导了全长 O-PS 的抗体。用 Ft.LVS::Δwzy 免疫可保护小鼠免受 A 型和 B 型土拉弗朗西斯菌的鼻内攻击,并通过体液和细胞机制诱导功能性免疫。